GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB) » Definitions » Pre-Tax Income

Nuvation Bio (Nuvation Bio) Pre-Tax Income : $-86.85 Mil (TTM As of Sep. 2021)


View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Nuvation Bio's pretax income for the three months ended in Sep. 2021 was $-21.98 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2021 was $-86.85 Mil. Nuvation Bio's pretax margin was %.


Nuvation Bio Pre-Tax Income Historical Data

The historical data trend for Nuvation Bio's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio Pre-Tax Income Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21
Pre-Tax Income
- -86.85

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Pre-Tax Income Get a 7-Day Free Trial - -20.40 -19.33 -21.98 -25.13

Competitive Comparison of Nuvation Bio's Pre-Tax Income

For the Biotechnology subindustry, Nuvation Bio's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nuvation Bio's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuvation Bio's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Nuvation Bio's Pre-Tax Income falls into.



Nuvation Bio Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Nuvation Bio's Pretax Income for the fiscal year that ended in Dec. 2020 is calculated as

Nuvation Bio's Pretax Income for the quarter that ended in Sep. 2021 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-22.791+-0.035+0+0.847+0
=-21.98

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-86.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuvation Bio  (NYSE:NUVB) Pre-Tax Income Explanation

Nuvation Bio's Pretax Margin for the quarter that ended in Sep. 2021 is calculated as

Pretax Margin=Pretax Income/Revenue
=-21.979/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuvation Bio Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuvation Bio (Nuvation Bio) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1500 Broadway, Suite 1401, New York, NY, USA, 10036
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.